RxDoctor Payments Data

Dale Goins, MD

Family Medicine · Hope, ARNPI 1063402485

Payments from drug & device makers

$487in general payments, 2019–2025

Across 31 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$82
  • Pfizer$67
  • Novartis$50
  • Lilly USA, LLC$40
  • Eisai Inc.$38
  • Harmony Biosciences LLC$36
  • plus $175 from 8 others

What the payments were for

  • Food & beverage$487100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$487 in reported general payments places this provider in the 45th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$6,336
Medicare patients
34
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban368$171,979
IngrezzaValbenazine Tosylate18$80,930
OzempicSemaglutide63$72,640
JanuviaSitagliptin Phosphate91$42,404
MounjaroTirzepatide28$40,165
LinzessLinaclotide58$33,563
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$31,413
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen943$30,669
MyrbetriqMirabegron62$29,741
Combivent RespimatIpratropium/Albuterol Sulfate31$25,616
FarxigaDapagliflozin Propanediol43$23,635
RexultiBrexpiprazole30$21,262
EntrestoSacubitril/Valsartan47$20,597
Lantus SolostarInsulin Glargine,hum.Rec.Anlog83$17,197
JardianceEmpagliflozin17$15,657

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$67$171,979368 claims
Novo NordiskOzempic, Rybelsus$32$85,97877 claims
Lilly USA, LLCMounjaro$40$40,16528 claims
AstraZenecaFarxiga, Symbicort, Bevespi Aerosphere$17$37,82585 claims
AbbVieLinzess, Lumigan$82$37,57273 claims
Astellas Pharma US IncMyrbetriq$12$29,74162 claims
NovartisEntresto$50$20,59747 claims
Johnson & JohnsonXarelto$25$6,09117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Hope

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →